E-Buy Home Inc. logo

E-Buy Home Inc. (EBYH)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 21
0
0%
$
2.71M Market Cap
- P/E Ratio
- Div Yield
580 Volume
0 Eps
$ 0.21
Previous Close
Add Transaction
Day Range
0.21 0.21
Year Range
0.16 0.24
Want to track EBYH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EBYH closed today higher at $0.21, an increase of 0% from yesterday's close, completing a monthly increase of 23.5294% or $0.04. Over the past 12 months, EBYH stock gained 30.8411%.
EBYH is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.0061%. On average, the company has fell short of earnings expectations by -0.226%, based on the last three reports.
E-Buy Home Inc. has completed 6 stock splits, with the recent split occurring on Jul 14, 2011.
The company's stock is traded on one exchange.

EBYH Chart

E-Buy Home Inc. (EBYH) FAQ

What is the stock price today?

The current price is $0.21.

On which exchange is it traded?

E-Buy Home Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is EBYH.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.71M.

Has E-Buy Home Inc. ever had a stock split?

E-Buy Home Inc. had 6 splits and the recent split was on Jul 14, 2011.

E-Buy Home Inc. Profile

Diversified Consumer Services Industry
Consumer Discretionary Sector
Yeshua Simon Shainberg CEO
OTC PINK Exchange
26827D107 CUSIP
US Country
- Employees
- Last Dividend
14 Jul 2011 Last Split
5 Apr 1999 IPO Date

Overview

Strainsforpains, Inc. is a pioneering entity in the field of medical marijuana, focusing on harnessing data to optimize patient care. The company has positioned itself as a critical interlocutor between medical cannabis research and patient welfare by developing a sophisticated data recommendation system. This technology leverages personal data alongside strain genetics to accurately match patients with the cannabis brand or strain most suited to their medical needs. Based in New York, New York, and incorporated in 1990, Strainsforpains has evolved into a crucial resource for medical specialists, dispensaries, and consumers seeking to navigate the complexities of medical cannabis treatments. The company's innovative approach is further underscored by its strategic partnership with GenBio, Inc., which is centered on the licensing of anti-inflammatory compounds for inclusion in Strainsforpains' CBD branded products, thus enhancing the efficacy and range of its offerings.

Products and Services

Strainsforpains, Inc. offers a variety of products and services designed to bridge the gap between cannabis research and patient needs:

  • Strainsforpains App: The cornerstone of the company’s product line is the Strainsforpains app. This user-centric application utilizes a scientific approach to determine the most appropriate cannabis brand or strain for patients, based on an analysis of personal data and strain genetics. It embodies the company's commitment to leveraging technology for the welfare of medical marijuana patients.
  • Partnership with GenBio, Inc.: Another significant aspect of Strainsforpains' service offering is its strategic partnership with GenBio, Inc. This collaboration aims to license specialized anti-inflammatory compounds that are then incorporated into Strainsforpains' CBD branded products. This partnership not only diversifies the company's product range but also enhances the therapeutic potential of its offerings, underscoring Strainsforpains' dedication to innovation in medical marijuana solutions.

Contact Information

Address: 447 Broadway
Phone: 646-481-4161